Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Riga Stradins University

ClinicalTrials.gov lists Riga Stradins University as lead sponsor of 16 trials. It has 1 active development program and 1 approved asset.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

7 0 2015 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 5 registered with a 2026 start date. The dashed outline is the pace from the 5 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs. 1 trial is registered to start in 2027 or later.

This page covers Riga Stradins University: 16 lead-sponsored trials and 0 legal-entity registrations.

Get the Riga Stradins University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (24)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Periodontitis 2
Acute Coronary Syndrome 1
Alveolar Bone Loss 1
Aortic Dissection 1
Bicuspid Aortic Valve Disease 1

Showing 5 of 24 disease areas.

Start your 14-day trial Email me all 24 disease areas as a PDF

Trials by start year as sponsor or collaborator (11)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 5
2025 4
2024 2
2023 3
2022 2
2021 2
2020 2
2019 2
2018 2
2016 1

Showing 10 of 11 years.

Start your 14-day trial Email me all 11 years as a PDF

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (1)

Active development programs
Drug Disease area Max phase Trials
Intervention Group Breast Neoplasms Not reported 1

Approved assets (1)

Approved assets
Drug Trials
Iodine 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
not enough data 1 of 1 on time (n=1)

Journals published in (76)

Shown in this order: most published in first.

Journals published in
Journal Publications
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 4
BMJ open 3
Circulation 3
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 3
Lancet (London, England) 3

Showing 5 of 76 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

Latest dated events (27)

Shown in this order: newest first.

Latest dated events
Date Event Source
2027-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-08-18 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-03-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 27 events.

Start your 14-day trial Email me all 27 events as a PDF

Biomarker capability evidence (16)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
EGFR Trial sponsor Named in trial inclusion criteria
ERBB2 Trial sponsor Named in trial inclusion criteria
ESR1 Trial sponsor Named in trial inclusion criteria
PGR Trial sponsor Named in trial inclusion criteria
SLC13A5 Trial sponsor Named in trial inclusion criteria

Showing 5 of 16 evidence rows.

Start your 14-day trial Email me all 16 evidence rows as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.